Brian C. Stephenson - Nov 16, 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Secretary, Treasurer & CFO
Signature
/s/ Brian C. Stephenson
Stock symbol
BBIO
Transactions as of
Nov 16, 2024
Transactions value $
-$310,186
Form type
4
Date filed
11/19/2024, 06:06 PM
Previous filing
Aug 20, 2024
Next filing
Nov 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Options Exercise +25.8K +30.28% 111K Nov 16, 2024 Direct F1
transaction BBIO Common Stock Tax liability -$310K -13.1K -11.78% $23.72 97.9K Nov 16, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Options Exercise $0 -778 -49.97% $0.00 779 Nov 16, 2024 Common Stock 778 Direct F1, F3
transaction BBIO Restricted Stock Units Options Exercise $0 -947 -20.01% $0.00 3.79K Nov 16, 2024 Common Stock 947 Direct F1, F4
transaction BBIO Restricted Stock Units Options Exercise $0 -17.4K -10% $0.00 156K Nov 16, 2024 Common Stock 17.4K Direct F1, F5
transaction BBIO Restricted Stock Units Options Exercise $0 -6.71K -7.14% $0.00 87.2K Nov 16, 2024 Common Stock 6.71K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 25,799 shares of Common Stock underlying the Reporting Person's RSUs.
F3 The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F4 The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F5 The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F6 The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.